TIMOTHY MASON: Open Payments
NPI 1992298962 · LEXINGTON, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 38 payments from 6 companies in 2025. Trend: 2023 $1,099 · 2024 $684 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $443 |
| ABBVIE INC. | 19 | $359 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Alkermes, Inc. | 2 | $49 |
| Smith+Nephew, Inc. | 2 | $44 |
| Novo Nordisk Inc | 1 | $21 |
Products named: VRAYLAR, BREZTRI, FARXIGA, REXULTI, ARISTADA, RENASYS GO v2 HOME, Ozempic, CREON.
Industry payments across NE — which companies pay providers there.
